| Aug 12 |
Wall Street Analysts See a 40.85% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
|
| Aug 9 |
BeiGene Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 8 |
Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)
|
| Aug 7 |
BeiGene GAAP ADS of -$1.15 beats by $1.20, revenue of $929.17M beats by $119.98M
|
| Aug 7 |
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
|
| Aug 1 |
NICE recommends BeiGene’s MZL tablet for NHS use
|
| Jul 24 |
BeiGene opens biologics facility in New Jersey, US
|
| Jul 23 |
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
|
| Jul 18 |
BeiGene names Aaron Rosenberg as CFO
|
| Jul 18 |
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
|
